- Home
- SGRY vs WGS Comparison
SGRY vs WGS Comparison
Compare SGRY & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGRY
- WGS
- Stock Information
- Founded
- SGRY 2004
- WGS 2017
- Country
- SGRY United States
- WGS United States
- Employees
- SGRY N/A
- WGS N/A
- Industry
- SGRY Hospital/Nursing Management
- WGS Retail: Computer Software & Peripheral Equipment
- Sector
- SGRY Health Care
- WGS Technology
- Exchange
- SGRY Nasdaq
- WGS Nasdaq
- Market Cap
- SGRY 2.8B
- WGS 2.4B
- IPO Year
- SGRY 2015
- WGS N/A
- Fundamental
- Price
- SGRY $22.69
- WGS $129.49
- Analyst Decision
- SGRY Buy
- WGS Strong Buy
- Analyst Count
- SGRY 8
- WGS 7
- Target Price
- SGRY $33.71
- WGS $99.29
- AVG Volume (30 Days)
- SGRY 1.7M
- WGS 717.1K
- Earning Date
- SGRY 08-05-2025
- WGS 10-28-2025
- Dividend Yield
- SGRY N/A
- WGS N/A
- EPS Growth
- SGRY N/A
- WGS N/A
- EPS
- SGRY N/A
- WGS 0.05
- Revenue
- SGRY $3,237,000,000.00
- WGS $362,321,000.00
- Revenue This Year
- SGRY $9.91
- WGS $35.84
- Revenue Next Year
- SGRY $9.70
- WGS $18.46
- P/E Ratio
- SGRY N/A
- WGS $2,672.76
- Revenue Growth
- SGRY 12.05
- WGS 48.70
- 52 Week Low
- SGRY $18.87
- WGS $28.86
- 52 Week High
- SGRY $33.90
- WGS $130.91
- Technical
- Relative Strength Index (RSI)
- SGRY 49.64
- WGS 69.85
- Support Level
- SGRY $22.45
- WGS $114.25
- Resistance Level
- SGRY $24.10
- WGS $130.33
- Average True Range (ATR)
- SGRY 0.72
- WGS 5.82
- MACD
- SGRY -0.06
- WGS -0.14
- Stochastic Oscillator
- SGRY 15.06
- WGS 93.05
About SGRY Surgery Partners Inc.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.